In addition, other investigators have shown that expression of the nuclear form of Survivin in breast and gastric carcinomas is an independent prognostic indicator of good prognosis in these tumours, suggesting that a loss of nuclear Survivin expression may play a role in tumour progression (Okada et al, 2001; Kennedy et al, 2003). Here, BIRC5 is linked to gastric carcinoma.